of Abcentra, cardiovascular researcher and clinician. "By utilizing a cutting-edge imaging modality, FORTIFY aims to test orticumab's ability to reduce arterial inflammation, pathogenic processes strongly implicated in risk of a major adverse...
FDA approval of a generic iron sucrose is an important advancement for patients with CKD and iron deficiency anemia and a testament to Viatris' advanced technical and manufacturing capabilities. This complex product was developed in-house, and...
Roche's innovative TAGS (Temperature-Activated Generation of Signal) technology, designed to streamline respiratory testing, and to ensure timely and accurate diagnoses for patients. The new test provides accurate PCR results for the four most...
evaluation (rule in or rule out) of autoimmune vasculitis for healthcare providers. Using only 10μl of patient serum, the test provides results for three key autoantibody markers - MPO, PR3, and GBM - in a single, comprehensive report. These...
the #1 Medical Aesthetic Skincare Brand Worldwide*, announces the launch of A.G.E. Interrupter Ultra Serum, the latest science-backed product in its A.G.E. line. Sagging skin is a top concern driving patients to dermatologists, and this serum...
convenient options for biologics," said Patrick Jeukenne, worldwide president of BD Pharmaceutical Systems. "BD's enhanced testing capabilities acquired through ZebraSci and the proven capabilities of the BD Libertas™ Wearable Injector technology...
our position among the animal health leaders in U.S. FDA ANADA approvals over the past several years, which is a testament to our team’s dedication to delivering high-quality, cost-effective pharmaceuticals to veterinarians and pet owners," said...
disease." LEQSELVI may cause serious side effects including serious infections, malignancies, thrombosis, gastrointestinal perforations, and certain laboratory abnormalities. There also may be an increased risk of mortality and major cardiovascular...
rapidly adopted and utilized high-throughput sequencing platform to date - ensures that researchers have access to the latest technology that provides reliable, swift, and cost-effective next-generation sequencing services, with customers already...
a great relief for patients and doctors who have no approved drug treatment available at present." AC102 has already been tested for safety and tolerability in a clinical study and is currently being examined in a Europe-wide Phase-2-study in...
results revalidated the same positive outcomes previously reported in two separate studies using different models. "This latest study continues to build on the mounting evidence that C15:0 is an essential nutrient to not only protect our long-term...
(18 items), mobility/ambulation (14 items), abnormal movements (7 items), hand/arm function (9 items) and gastrointestinal health (3 items). Outcomes were assessed among "affected" participants, defined as those with a baseline score of at least 2...
Alafair Biosciences, Inc., a leading innovator in medical device technology, is pleased to announce the first patient enrolled at UC Davis Foot and Ankle Orthopaedics Clinic, as part of a prospective, multi-center, controlled case series...
biotechnology research. High-throughput screening (HTS) is a drug discovery process that allows for the rapid testing of thousands of chemical compounds to identify potential new medicines. The agreement signifies a shared commitment to deploy...
patients with unresectable or metastatic NSCLC whose tumors have activating HER2 mutations, as detected by an FDA-approved test, and who have received a prior systemic therapy.4 This was a positive step forward for patients with NSCLC whose tumors...
that may arise during the drug discovery phase, Samsung Biologics aims to enhance clinical success rates. "The latest service launch reflects our unwavering commitment to driving innovation by improving drug success rates and creating new...
along with associated services for descriptive and functional cell characterization, compound screening and toxicology testing. The company’s mission is to supply a diverse range of human disease models, derived from ethically sourced patient and...
NSCLC,” said David Hung, M.D., Founder, President and Chief Executive Officer of Nuvation Bio. “We believe one of the greatest threats to ROS1-positive lung cancer patients is disease progression, especially in the first-line setting. In pivotal...
These transformative capabilities give the pharmaceutical industry the practical means to pivot beyond animal testing and into truly human-relevant territory. “AVA gives scientists unprecedented experimental capacity with the biological depth of...
infection during and after treatment with HADLIMA, including the possible development of tuberculosis (TB) in patients who tested negative for latent TB infection prior to initiating therapy. Lymphoma and other malignancies, some fatal, have been...
